Moxetumomab pasudotox in relapsed/refractory hairy cell leukemiaRobert J. Kreitman, Francis J. Giles, Lionel Karlin et al.|Leukemia|2018Cited by 250
Outcome of Intensively Treated Elderly AML Patients Reported to the Harmony Alliance Compares Well to Outcome of Control Patients of the Prospective Randomized HOVON 103 Study in Elderly AMLSjoerd J. F. Hermans, Jan J. Cornelissen, Jurjen Versluis et al.|Blood|2023Cited by 1